30 related articles for article (PubMed ID: 30509085)
1. FOXO1: Another avenue for treating digestive malignancy?
Shi F; Li T; Liu Z; Qu K; Shi C; Li Y; Qin Q; Cheng L; Jin X; Yu T; Di W; Que J; Xia H; She J
Semin Cancer Biol; 2018 Jun; 50():124-131. PubMed ID: 28965871
[TBL] [Abstract][Full Text] [Related]
2. Multidimensional data analysis revealed thyroiditis-associated TCF19 SNP rs2073724 as a highly ranked protective variant in thyroid cancer.
Ruan X; Liu Y; Wu S; Fu G; Tao M; Huang Y; Li D; Wei S; Gao M; Guo S; Ning J; Zheng X
Aging (Albany NY); 2024 Apr; 16(7):6488-6509. PubMed ID: 38579171
[TBL] [Abstract][Full Text] [Related]
3. TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
Zhou ZH; Chen G; Deng C; Tang JM; Xie L; Zhou HY; Ye X; Zhang DK; Shi RQ; Tian D; Qiao GB; Ben XS
Cell Biol Int; 2019 Dec; 43(12):1416-1424. PubMed ID: 31141247
[TBL] [Abstract][Full Text] [Related]
4. The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif.
Huang X; Zhang C; Shang X; Chen Y; Xiao Q; Wei Z; Wang G; Zhen X; Xu G; Min J; Shen S; Liu Y
Cell Death Dis; 2024 May; 15(5):335. PubMed ID: 38744853
[TBL] [Abstract][Full Text] [Related]
5. TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway.
Tian Y; Xin S; Wan Z; Dong H; Liu L; Fan Z; Li T; Peng F; Xiong Y; Han Y
Transl Oncol; 2024 Jul; 45():101978. PubMed ID: 38701650
[TBL] [Abstract][Full Text] [Related]
6. Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway.
Tufail M; Hu JJ; Liang J; He CY; Wan WD; Huang YQ; Jiang CH; Wu H; Li N
J Transl Med; 2024 Jan; 22(1):15. PubMed ID: 38172946
[TBL] [Abstract][Full Text] [Related]
7. Diosmin Promotes Myogenesis via Activating the Akt/FOXO1 Pathway to Facilitate the Proliferation of C2C12 Myoblasts.
Zhang D; Zhang X; Liu Z; Ma X; Li H; Shen M; Chen J; Liu H
J Agric Food Chem; 2023 Dec; 71(49):19705-19716. PubMed ID: 38029323
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer and single-cell analysis reveals
Yu H; Chen Q; Wang Z; Qian X; Pan Y
Front Genet; 2022; 13():1009325. PubMed ID: 36568373
[No Abstract] [Full Text] [Related]
9. Immunotherapeutic Value of Transcription Factor 19 (TCF19) Associated with Renal Clear Cell Carcinoma: A Comprehensive Analysis of 33 Human Cancer Cases.
Cheng X; Hou J; Wen X; Dong R; Lu Z; Jiang Y; Wu G; Yuan Y
J Oncol; 2022; 2022():1488165. PubMed ID: 36111242
[TBL] [Abstract][Full Text] [Related]
10. Genetics of PlGF plasma levels highlights a role of its receptors and supports the link between angiogenesis and immunity.
Ruggiero D; Nutile T; Nappo S; Tirozzi A; Bellenguez C; Leutenegger AL; Ciullo M
Sci Rep; 2021 Aug; 11(1):16821. PubMed ID: 34413389
[TBL] [Abstract][Full Text] [Related]
11. Role of Forkhead Box O Proteins in Hepatocellular Carcinoma Biology and Progression (Review).
Yang S; Pang L; Dai W; Wu S; Ren T; Duan Y; Zheng Y; Bi S; Zhang X; Kong J
Front Oncol; 2021; 11():667730. PubMed ID: 34123834
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Transcription Factor FoxO1 in the Pathogenesis of Polycystic Ovary Syndrome.
Xu R; Wang Z
Front Physiol; 2021; 12():649295. PubMed ID: 33746783
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MIR194-2HG Promotes Cell Proliferation and Metastasis via Regulation of miR-1207-5p/TCF19/Wnt/β-Catenin Signaling in Liver Cancer.
Xu G; Zhu Y; Liu H; Liu Y; Zhang X
Onco Targets Ther; 2020; 13():9887-9899. PubMed ID: 33116574
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.
Alshabi AM; ; Shaikh IA; Vastrad C
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31311202
[No Abstract] [Full Text] [Related]
15. TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK/FOXO1 signaling pathway.
Zeng CX; Fu SB; Feng WS; Zhao JY; Li FX; Gao P
Neoplasma; 2019 Jan; 66(1):46-53. PubMed ID: 30509085
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EPS8L3 promotes cell proliferation by inhibiting the transactivity of FOXO1 in HCC.
Zeng CX; Tang LY; Xie CY; Li FX; Zhao JY; Jiang N; Tong Z; Fu SB; Wen FJ; Feng WS
Neoplasma; 2018 Sep; 65(5):701-707. PubMed ID: 29940761
[TBL] [Abstract][Full Text] [Related]
17. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism.
Chiu AP; Tschida BR; Sham TT; Lo LH; Moriarity BS; Li XX; Lo RC; Hinton DE; Rowlands DK; Chan CO; Mok DKW; Largaespada DA; Warner N; Keng VW
Mol Cancer Res; 2019 Jul; 17(7):1582-1593. PubMed ID: 30975706
[TBL] [Abstract][Full Text] [Related]
18. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
